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CD4 Regulatory T Cells Prevent Lethal Autoimmunity
in IL-2R-Deficient Mice: Implications
for the Nonredundant Function of IL-2
marrow or T cells, respectively. In the latter situation,
normal CD8 T cells appeared to preferentially function
to actively eliminate the IL-2R/ T cells. Wolf et al.
(2001) demonstrated that uncontrolled antigen-induced
expansion of IL-2/ CD4 TCR transgenic T cells in
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adoptively transferred nude mice was inhibited whenMiami, Florida 33101
these mice received a coinjection of either normal un-
fractionated CD4 or purified CD4CD25 T cells. Al-
though the wild-type donor CD4 T cells represented aSummary
potential source of IL-2 to sensitize the IL-2/ TCR
transgenic T cells for AICD, these authors argued thisLethal autoimmunity associated with IL-2R-deficient
possibility was unlikely when CD4CD25 T cells weremice is prevented after thymic transgenic expression
transferred because CD4CD25 T cells do not secreteof wild-type IL-2R in IL-2R/ mice (Tg / mice).
IL-2. Although these two studies differ on the relativeHere, we show that CD4CD25 regulatory T cells were
importance of CD4 versus CD8 T cells, both indicatenot readily detected in IL-2R/mice, but the produc-
that some abnormalities associated with IL-2/IL-2R defi-tion of functional CD4CD25 T cells was reconstituted
ciency were prevented by the action of normal T lympho-in Tg / mice. Adoptive transfer of normal CD4
cytes. However, it is still unknown whether autoimmuneCD25 T cells into neonatal IL-2R-deficient mice pre-
disease in these knockout mouse models is preventedvented this lethal autoimmune syndrome. The CD4
by regulatory T cells.CD25 T cells in disease-free adult IL-2R-deficient
In other experiments, our laboratory has reported therecipient mice were present at a near normal fre-
unexpected finding that transgenic thymic-specific ex-quency, were solely donor-derived, and depended on
pression of IL-2R in IL-2R knockout mice (designatedIL-2 for expansion. These observations indicate that
Tg/) prevented lethal autoimmunity associated withthe essential function of the IL-2/IL-2R system primar-
IL-2R/ mice (Malek et al., 2000). Unlike IL-2R/ily lies at the level of the production of CD4CD25
mice on the C57BL/6 genetic background with a liferegulatory T cells.
span of only 8–12 weeks (Suzuki et al., 1995), Tg /
mice lived at least 12–16 months without evidence ofIntroduction
obvious autoimmunity (Malek et al., 2000). Importantly,
from the earliest time tested (3 weeks) through 12–16IL-2 functions after binding to the high-affinity IL-2R
months of age, the peripheral T lymphocytes fromcomprised of , , and c subunits. These latter two
Tg / mice were essentially nonresponsive to IL-2subunits are also components of other cytokine recep-
(Malek et al., 2000, 2001). These experiments do nottors; i.e., IL-2R is a component of the IL-15R while c
support a model in which autoimmunity in IL-2- and IL-is a subunit of the IL-4R, IL-7R, IL-9R, IL-15R, and IL-
2R-deficient mice is the result of an intrinsic defect in21R (Asao et al., 2001; He and Malek, 1998). For some
their autoreactive T lymphocytes and suggest an impor-time, IL-2 has been considered the most important T cell
tant thymic function for the IL-2R.growth factor to greatly expand the number of recently
The notion that the IL-2/IL-2R is essential during thy-activated antigen-specific T lymphocytes (Nelson and
mic development has been largely dismissed becauseWillerford, 1998). Therefore, it was quite unexpected
thymic cellularity is normal early in life in IL-2, IL-2R,
that mice deficient in IL-2, IL-2R, or IL-2R are charac-
and IL-2R knockout mice (Sadlack et al., 1995, 1993;
terized by T cell lymphoproliferation and lethal autoim-
Schorle et al., 1991; Suzuki et al., 1995; Willerford et al.,
munity (Sadlack et al., 1995, 1993; Suzuki et al., 1995; 1995). This conclusion assumes that the key role for intra-
Willerford et al., 1995). thymic IL-2/IL-2R is in promoting thymocyte growth. An
Besides its action as a growth factor, extended prolif- alternate view, which we previously proposed to explain
eration to IL-2 sensitizes growing T cells to undergo the function of thymic transgenic IL-2R, is that thymic
apoptosis, or activated-induced cell death (AICD), upon IL-2/IL-2R is essential for regulating self-reactivity (Ma-
restimulation through the TCR (Kneitz et al., 1995; Le- lek et al., 2000), during either negative selection or the
nardo, 1991; Van Parijs and Abbas, 1998; Van Parijs et production of CD4CD25 T regulatory cells. Consistent
al., 1997). It is generally considered that lack of AICD in with this concept, IL-2 producing cells are detected
IL-2-, IL-2R-, and IL-2R-deficient mice causes their within the thymus, especially at the cortical/medullary
autoimmunity and imbalanced homeostasis. However, junction, a key thymic site for selection and maturation
several recent studies point to other explanations for (Bassiri and Carding, 2001; Yang-Snyder and Rothen-
the aberrant function of IL-2R/ T cells. For example, berg, 1998), and CD4CD8 transitional intermediate
Suzuki et al. (1999) showed that abnormally activated thymocytes express IL-2R, , and c (Hanke et al.,
IL-2R/ T cells were not detected in either lethally 1994; He et al., 1995; Jordan et al., 2001).
irradiated or immunodeficient mice that were trans- In order to better define the essential role of IL-2/
planted with a mixture of normal and IL-2R/ bone IL-2R in controlling autoimmune responses and T cell
hyperactivity, the present study was initiated to investi-
gate the mechanism by which thymic IL-2R expression3 Correspondence: tmalek@med.miami.edu
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Figure 1. Negative Selection in IL-2R-Defi-
cient Mice
FACS analysis of V subgroup expression by
CD4 T cells from the lymph nodes of DBA/
2 (A) and BALB/c (B) mice of the indicated
genotypes. Non-V-deleting normal C57BL/
6 lymph node T cells were included as a refer-
ence. Data are represented as the % positive
cells for the indicated V subgroups after
staining with PE-CD4, Cychrome-CD8, and
FITC-TCR subgroup (A), or FITC-CD4, Cych-
rome-CD8, biotin anti-V subgroup, and PE-
streptavidin (B). WT refers to littermate mice
whose genotype was IL-2R/ or /. Data
represent mean  SE for five to six (A) and
eight (B) mice/group. A * within a graph speci-
fies a bar to small to be seen.
in IL-2R/ mice averted lethal autoimmunity. These Thymic Transgenic IL-2R Restores CD4CD25
T Cells in IL-2R/ Miceexperiments support a model in which the nonredundant
role for the IL-2R lies primarily at the level of CD4CD25 As CD4CD25 regulatory T cells arise during thymic
development (Sakaguchi, 2000; Shevach, 2000), anotherT cells.
potential function for IL-2R during thymic development
is in the production of these cells. As IL-2/ mice haveResults
been reported not to contain CD4CD25 T cells (Pa-
piernik et al., 1997), we investigated whether CD4Thymic Negative Selection in IL-2R/ Mice
Negative selection of CD8 T cells is normal in IL-2- CD25T cells were present in Tg/mice. Representa-
tive FACS dot plots for the expression of CD4CD25deficient mice (Kra¨mer et al., 1994; Suzuki et al., 1997).
However, lethal disease in IL-2R-deficient mice is due T cells from the thymus and lymph nodes of / lit-
termate, IL-2R-deficient, and Tg / mice are illus-to autoimmune CD4 T cells (Suzuki et al., 1995), raising
the possibility that signaling through IL-2R might be trated in Figures 2A and 2C. From this analysis,
CD4CD25 T cells were readily identified in the thymusrequired for thymic negative selection of CD4 T cells.
One means to investigate negative selection is to evalu- (Figures 2A and 2B), lymph nodes (Figures 2C and 2D),
and spleen (data not shown) of / littermate andate the ability of endogenous superantigens to delete T
cells expressing particular V TCR subgroups during Tg / mice, whereas the fraction of CD4CD25 T
cells was reduced in the thymus (Figures 2A and 2B)thymic development (Herman et al., 1991). Therefore,
IL-2R deficiency was bred onto mice of the BALB/c and almost absent in the lymph nodes (Figures 2C and
2D) and spleen (not shown) from IL-2R/ mice.and DBA/2 genetic backgrounds, where such deletion
readily occurs, and compared to V expression by When compared to littermate/control mice, analy-
sis of the thymus (Figure 2B) and lymph nodes (FigureC57BL/6 T cells that do not undergo superantigen-medi-
ated negative selection (Figure 1). For those V sub- 2D) of IL-2/ and IL-2R/ mice revealed an approxi-
mately 2- and 5-fold reduction, respectively, in the per-groups that we examined, deletion is expected for T
cells expressing V3, 5, 6, 8.1, 9, 11, and 12 and for centage of CD4CD25 T cells. Furthermore, the lymph
nodes of IL-2R/ mice essentially lacked CD4 T cellsV5, 11, and 12 from DBA/2 and BALB/c mice, respec-
tively. With possibly one exception, the extent of dele- that expressed a high level of CD25. By contrast, both
the thymus (Figure 2B) and lymph nodes (Figure 2D) oftion of CD4 T cells from littermate control and IL-
2-deficient DBA/2 (Figure 1A) and BALB/c (Figure 1B) Tg / mice contained approximately a 2-fold higher
fraction of CD4CD25 T cells when compared to con-mice was equivalent. Only deletion of V12-expressing
CD4 T cells from BALB/c IL-2R/ mice appeared im- trol littermate mice. This leads to a higher number of
CD4CD25 T cells, which may be the result of broaderpaired (Figure 1B). In no instance was deletion of any
V subgroup hindered when CD8 T cells were similarly expression of IL-2R in the thymus of the Tg / mice,
which may correspondingly favor a greater productionexamined from DBA/2 and BALB/c IL-2R/ mice (data
not shown). These data indicate that IL-2R function is of these T cells.
One property of CD4CD25 regulatory T cells is theirnot mandatory for most thymic negative selection. Thus,
it is highly unlikely that thymic IL-2R in Tg / mice capacity to inhibit anti-CD3-induced proliferation by
CD4CD25 T cells in vitro (Thornton and Shevach,prevented autoimmunity by correcting a failure to elimi-
nate self-reactive T cells. 2000). Therefore, CD4CD25 T cells were purified
IL-2R and the Production of T Regulatory Cells
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Figure 2. Presence and Function of CD4CD25 Regulatory T Cells in Tg / and IL-2R-Deficient Mice
(A–D) Representative FACS dot plots of thymocytes (A) or lymph node cells (C) from mice of the indicated IL-2R genotypes on the C57BL/
6 genetic backgrounds after staining with FITC-CD4, Cychrome-CD8, biotin-anti-CD25, and PE-streptavidin. Dot plots labeled “Control”
represent cells that were preincubated with an excess of unlabeled anti-CD25 prior to adding the staining reagents. Numbers within the dot
plots indicate the % of cells contained with the gated region. The % of CD4 T cells that coexpressed CD25 in the thymus (B) and lymph
nodes (D) was calculated after gating CD4 single-positive thymocytes and lymph node cells followed by determining the % of cells that were
CD4CD25 minus the % of negative control stained CD4CD25 cells, determined by inhibition with unlabeled anti-CD25. The number of
mice in each group is indicated within the bar.
(E) The inhibitory activity of purified CD4CD25 T cells for anti-CD3-induced proliferation. The indicated number (104 ) of purified unfraction-
ated CD4 T cells and T-depleted mitomycin-treated splenic accessory cells (5  104 /well) was cultured in the absence or presence of the
indicated number (104 ) of purified CD4CD25 T cells (designated CD4R), as listed below the x axis, with anti-CD3 (1 g/ml) for 48 hr. 3 H-
thymidine was added during the last 6 hr of culture. The IL-2R genotype is listed in parentheses to the right of the purified CD4 T cell
population.
from / control littermate and Tg / spleen cells. tered to neonatal BALB/c IL-2R/ mice. When com-
The typical level of purification of these cells is shown pared to C57BL/6 IL-2R/ mice, BALB/c IL-2R-
in Figure 3A (lower left panel). The purified CD4CD25 deficient mice have a more severe form of autoimmunity
T cells from Tg / mice were CD4 regulatory T cells with a shorter life span (3–5 weeks for BALB/c, 8–12
based on their hyporesponsiveness to anti-CD3 in vitro weeks for C57BL/6).
(data not shown) and their capacity to inhibit anti-CD3- Figure 3B summarizes the incidence of autoimmunity
induced proliferation by C57BL/6 CD4 T cells in a man- in all neonatal recipient BALB/c IL-2R/ mice. The
ner comparable to CD4CD25 T cells from control mice adoptive transfer of as few as 30,000 purified CD4
(Figure 2E). Thus, thymic expression of IL-2R in IL- CD25 T cells prevented lethal autoimmunity and abnor-
2R/ mice restored the production of functional CD4 malities associated with IL-2R-deficient mice, i.e., an
regulatory T cells. absence of hemolytic anemic, antinuclear DNA autoanti-
bodies, splenomegaly, and impaired T cell proliferation
in vitro. This number of purified CD4CD25 representsAdoptive Transfer of CD4CD25 T Cells to IL-2R/
the lower limit necessary to affect this autoimmune syn-Mice Prevents Lethal Autoimmunity
drome because 10,000 CD4CD25T cells were ineffec-To investigate whether the absence of peripheral CD4
tive and those mice that received 30,000 CD4CD25CD25 T cells is indeed responsible for autoimmunity
T cells exhibited a somewhat intermediate response,in IL-2R-deficient mice, unfractionated, CD25-enriched,
i.e., lack of autoimmunity but somewhat enlarged lymphor CD25-depleted CD4 T cells were prepared from nor-
mal BALB/c spleen cells (Figure 3A) and then adminis- nodes with an increased fraction of activated T cells
Immunity
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Figure 3. Effect of Adoptive Transfer of Normal CD4CD25 T Cells into BALB/c IL-2R/ Mice
Neonatal BALB/c mice of the indicated IL-2R genotype were adoptively transferred with the indicated number of donor cells (B) or with
1–3  105 CD4CD25, 0.3  105 unfractionated CD4, or 1  105 CD4CD25 T cells (C–F) and analyzed 8–26 weeks later.
(A) Representative FACS dot plots for the purity of donor CD4 T cell subsets. The indicated cell populations were purified from spleen cells
from normal mice, and the purity was assessed by FACS after staining with FITC-anti-CD4 and PE-CD25. Numbers within the dot plots indicate
the % of cells contained with the gated region.
(B) Summary of the instances of autoimmune disease in adoptively transferred BALB/c IL-2R/ mice.
(C) Hematoxylin-eosin fixed sections from the spleen (100) and liver (400) where “treated” refers to CD4CD25 donor T cells.
(D–F) Lymph node cellularity of the axillary and brachial nodes determined by manual hemacytometer counting in the presence of trypan blue
(D), the hematocrit (E), and antinuclear autoantibodies (ANA) titers (F) were determined for mice of the indicated IL-2R genotype. Data in
(D–F) represent mean  SE for 5–12 mice/group.
(data not shown). By contrast, adoptive transfer of 3- and fore, indicate that CD4CD25 T cells represent the ma-
jor cellular component that prevented autoimmunity.10-fold more unfractionated or CD25-depleted CD4 T
cells, respectively, were necessary to prevent autoim- When compared to untreated IL-2R/ BALB/c mice,
all IL-2R/ BALB/c mice that received 1–3 105 puri-munity. In fact, 8 of 12 mice that received 1  105
CD4CD25 T cells had a life span of	7 weeks, indica- fied CD4CD25 T cells were disease free as revealed
by normal histopathology of the spleen and liver (Figuretive of severe autoimmune disease. These data, there-
IL-2R and the Production of T Regulatory Cells
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3C) as well as the lack of lymphoadenopathy (Figure transferred IL-2R/ mice exhibited near normal prolif-
erative responses to anti-CD3 and PMA plus either IL-43D), hemolytic anemia (Figure 3E), and antinuclear auto-
antibodies (Figure 3F). Histological analysis of BALB/c or IL-7. Thus, after suppressing the development of au-
toimmunity in vivo, T cells from the adoptively trans-IL-2R/ mice not only indicated periportal chronic in-
flammation consisting of large atypical lymphocytes in ferred IL-2R/ mice, at least initially, vigorously re-
sponded upon challenge in vitro.the liver but also lymphocyte proliferation of the periart-
erialis T cell areas and lymphoid follicles with extension Since the T cells from adoptively transferred IL-2R/
mice responded to anti-CD3, these T blasts were restim-of the marginal zones in the spleen (Figure 3C). Abnormal
pathology in IL-2R/ mice was also noted in the testis, ulated with cytokines, and the resulting proliferation was
compared to T blasts generated from untreated or adop-lung, kidney, intestine, and lymph nodes (data not
shown). All these tissues were normal in the adoptively tively transferred normal mice (Figure 4D). The T blasts
derived from the adoptively transferred IL-2R/ micetransferred IL-2R/ mice that received CD4CD25 T
cells. Thus, the health pattern of IL-2R/ mice treated were extremely hyporesponsive to IL-2 and IL-15, con-
sistent with the notion that most of the T cells that initiallywith CD4CD25 T cells closely paralleled that seen for
untreated normal mice or adoptively transferred / responded to anti-CD3 were derived from the recipient.
Furthermore, these T blasts also generated much loweror / littermate control mice. By contrast, IL-2R/
recipient mice that received unfractionated CD4 or proliferative responses to IL-4 and IL-7. Collectively, in
the absence of autoimmunity, the peripheral T cells ofCD4CD25T cells, that survived more than 7 weeks but
were judged to have autoimmunity, exhibited disease the adoptively transferred IL-2R/mice exhibited rela-
tively normal cellularity (see Figure 3D), lacked an acti-symptoms comparable to those of untreated IL-2R-
deficient mice (Figures 3D–3F). vated phenotype, were initially selectively and poorly
responsive to IL-2 and IL-15 but not anti-CD3 and later
became hyporesponsive to IL-4 and IL-7. This responseImmunological Properties of Autoimmune-free
pattern is identical to that reported for our Tg/mouseBALB/c IL-2R/ Mice
model (Malek et al., 2000, 2001) in which thymic targetedThe cell surface phenotype and in vitro proliferative ca-
IL-2R expression prevented autoimmunity in IL-2R/pacity were evaluated for lymphocytes obtained from
mice. Thus, restoring CD4CD25 T cells in IL-2R/IL-2R/mice that received CD4CD25 T cells at least
mice, either by transgenic IL-2R expression or the7 weeks earlier. FACS analysis of T cells from one
transfer of CD4CD25 T cells, leads to prevention ofBALB/c IL-2R/ mouse, that was assayed 180 days
autoimmune disease and at least a partial recovery ofafter it received CD4CD25 T cells, is compared to an
responsiveness to T cell stimuli.identically treated littermate control mouse as well as to
untreated wild-type and IL-2R/ BALB/c mice (Figure
4A). The results from the FACS analysis of all such mice Donor Cell Engraftment and Expansion
in C57BL/6 IL-2R/ Recipient Micethat received 1–3  105 CD4CD25 T cells are shown
in Figure 4B. Although IL-2R/ mice contained a low To define the phenotype and functional activity of the
donor cell inoculum, 1  105 congenic CD45.1 CD4fraction of CD4CD25 T cells and essentially lack
CD4CD25high T cells (Figures 2C, 4A, and 4B), both CD25 C57BL/6 T cells were adoptively transferred to
neonatal C57BL/6 (CD45.2) IL-2R/ recipient mice.CD4CD25, including CD4CD25high, T cells were
readily detected in the adoptively transferred IL-2R/ Three mice (#1–3) were disease free, while one (#4) ex-
hibited obvious symptoms of autoimmunity (see below).mice, albeit at a somewhat lower percentage when com-
pared to normal mice (Figure 4B). Unlike IL-2R/ mice, FACS analysis 7–9 weeks after adoptive transfer of the
“cured” (#1–3) and the autoimmune (#4) recipient IL-the adoptively transferred IL-2R/mice lacked an acti-
vated phenotype as assessed by examining the fraction 2R/ mice revealed that approximately 3%–5% of the
total cells in the lymph node and spleen were of donorof CD4 (Figures 4A and 4B) and CD8 (data not shown)
T cells that expressed CD69, a high level of CD44 origin, while very few donor cells were detected in the
thymus (Figures 5A and 5B). This level of engraftment(CD44high), and an intermediate to low level of CD62L
(CD62int). In fact, the expression of CD69 and CD44high corresponded to at least a 15- to 20-fold expansion of
the initial donor cell inoculum of 1 105 cells (Figure 5C).closely paralleled that observed for normal or adoptively
transferred IL-2R/ control mice. One difference be- By contrast, essentially no donor cells were detected in
adoptively transferred IL-2R/ control recipient micetween the adoptively transferred IL-2R/mice with other
mice examined is that the lymph nodes consistently con- (Figure 5B), indicating that as the control mice matured
the production of host T cells was favored over thetained a lower fraction of CD8 T cells (Figure 4B).
When spleen cells from IL-2R/ mice that were donor inoculum. Representative FACS dot plots showed
that 
90% of the engrafted donor cells were T lympho-adoptively transferred with CD4CD25 T cells were
stimulated with PMA and cytokines or anti-CD3, as ex- cytes. For the cured recipients (#1–3), most donor T cells
were CD4 (Figures 5A and 5D). However, unexpectedly,pected, they exhibited a selective and marked decrease
in the proliferative response to PMA and IL-2 (Figure all recipient mice also contained donor-derived CD8 T
cells, and almost all donor T cells in autoimmune mouse4C). This lower response, which on average was about
20% of that generated by untreated BALB/c spleen cells, #4 were CD8 (Figures 5A and 5D). This latter result
suggests that engraftment by CD8 donor T cells wasmust reflect chimerism by the donor inoculum. By con-
trast, untreated IL-2R/ spleen cells were essentially ineffective in preventing autoimmunity. FACS analysis of
purified CD4CD25donor T cells at the time of adoptiveunresponsive to all these stimuli, as previously reported
(Malek et al., 2000; Suzuki et al., 1995). The adoptively transfer indicated that they were contaminated by1%
Immunity
172
Figure 4. Immunological Profile of BALB/c IL-2R/ Mice Adoptively Transferred with CD4CD25 T Cells
(A) Representative FACS profiles of lymph node cells from mice of the indicated genotypes treated with 3  105 CD4CD25 T cells 180 days
previously. Cells were stained with FITC-CD4, Cychrome-CD8, and either biotin-anti-CD25, -CD44, -CD62L, or -CD69, and PE-streptavidin.
Histograms represent the staining for the indicated surface protein after gating CD4 T cells. Numbers within the dot plots or histograms
indicate the % of cells contained with the designated region.
(B) Summary of lymph node staining for the indicated surface proteins from all mice that received 1–3  105 CD4CD25 T cells.
(C and D) Proliferation by fresh spleen cells (2 105 /well) (C) or T cells blasts (2  104 /well) (D), obtained after a 2 day culture with anti-CD3,
of the indicated genotype after stimulation with PMA (10 ng/ml), IL-2 (50 U/ml), IL-4 (10 ng/ml), IL-7 (50 ng/ml), IL-15 (10 ng/ml), or anti-CD3
(5% culture supernatant), as indicated below the x axis, for 48 or 24 hr, respectively. Data in (B–D) represent mean  SE for 5–12 mice/group.
A * within a graph specifies a bar too small to be seen.
CD8 T lymphocytes (data not shown). Thus, these few control mice or adoptively transferred BALB/c IL-2R/
mice that lacked autoimmunity (see Figure 4). The ex-CD8 T cells readily expanded during the 7–9 weeks
within the IL-2R/ recipient mice. pression of CD44, CD62L, and CD69 on T cells from
mouse #4 exhibited an activated phenotype, compara-FACS analysis revealed that80% of the donor CD4
T cells in mice #1–3 coexpressed CD25 (Figure 5E). ble to that detected for T cells from autoimmune un-
treated IL-2R/ mice (see Figure 4).These CD4CD25 T cells expressed a high level of
CD25 and also coexpressed a high level of CD44 and CD4CD25 donor cells in the adoptively transferred
IL-2R/ mice were isolated from mice #1–3 or froman intermediate level of CD62L, a phenotype that typifies
CD4CD25 regulatory T cells (Itoh et al., 1999). Most similarly treated control mice (Figure 6A) and tested for
their capacity to inhibit anti-CD3-induced proliferationdonor CD8 T cells from all four mice expressed high
levels of CD44, while a much smaller fraction of these by purified unfractionated normal CD4 T cells (Figure
6B). FACS analysis of the purified cells indicated thatcells expressed CD25, CD69, and CD62Lint (Figure 5F).
With respect to the recipient IL-2R/ CD4 and CD8 essentially all the CD4CD25 T cells from the IL-2R/
recipient were donor derived, whereas the CD4CD25T cells, those from mice #1–3 had essentially no CD25
T cells. However, these T cells expressed CD69, T cells isolated from the control IL-2R/ mice were
solely of recipient origin (Figure 6A). In each case, theCD44high, and CD62Lint in a manner equivalent to normal
IL-2R and the Production of T Regulatory Cells
173
Figure 5. Donor Cell Engraftment after Adoptive Transfer of C57BL/6 IL-2R/ Mice with Normal CD4CD25 T Cells
C57BL/6 IL-2R/ neonatal mice (n  4) received 1  105 CD4 CD25 T cells from B6.SJL-Ptprc/BoAiTac mice, congenic for CD45 and
identified by expression of CD45.1, and were analyzed 7–9 weeks later.
(A) FACS analysis of engraftment of one autoimmune-free (#1) and one autoimmune (#4) mouse. Lymph node cells were stained with biotin-
anti-TCR/PE-streptavidin, Cychrome-CD4 or -CD8, and FITC-CD45.1. Numbers within the dot plots indicate the % of cells contained within
the designated region.
(B) Donor cell engraftment is represented by the percentage (mean  SE) of CD45.1 cells in each organ, as listed below the x axis, for
adoptively transferred IL-2R/ (n  4) and control IL-2R/ (n  4) recipient mice.
(C) Donor cells expansion in adoptively transferred IL-2R/ mice was calculated from the % CD45.1 cells in the spleen and lymph nodes
(axillary and brachial) times the number of cells in these organs.
(D) The % of donor-derived CD4 or CD8 lymph node T cells in IL-2R/ recipient mice (#1 to #4) was determined by gating on CD45.1
cells and evaluating the fraction of cells that stained for CD4 or CD8, using FACS profiles as shown in (A).
(E and F) The cell surface phenotype of donor- and recipient-derived CD4 (E) and CD8 (F) T cells. Lymph node cells were tripled stained
with either Cychrome-CD4 (E) or Cychrome-CD8 (F), FITC-CD45.1, and either biotin-anti-CD25, -CD44, -CD62L, -CD69, and PE-streptavidin.
Data are represented as the % of either donor (CD45.1) or recipient (CD45.1) CD4 (E) or CD8 (F) T cells that express the indicated marker,
as listed below the x axis, by gating on the appropriate subsets of cells. Figure 4A indicates the placement of the markers that was used to
enumerate the % positive, % high, or % intermediate level of expression. (Note that there are no donor-derived CD4 T cells in mouse #4).
A * within a graph specifies a bar too small to be seen.
inhibitory activity (mean SE) of anti-CD3-induced pro- CD45.1CD4CD25 C57BL/6 T cells (
98% CD4)
(Figure 6C) were adoptively transferred to C57BL/6 neo-liferation by donor CD4CD25 T cells (71.6 23.9) was
comparable to that by the control CD4CD25 T cells natal IL-2R/ mice, and the recipient mice were ana-
lyzed 26 days later. At this time, untreated C57BL/6(70.9  12.4) when cocultured with normal unfraction-
ated CD4 T cells (Figure 6B). Furthermore, both groups IL-2R/ mice exhibited obvious symptoms related to
autoimmune disease including lymphoadenopathy (Fig-of CD4CD25 T cells failed to proliferate when cultured
alone with anti-CD3 and accessory cells (data not ure 6D), a high proportion of activated T cells in the
spleen (Figure 6E) and lymph nodes (Figure 7D, groupshown). Thus, donor-derived CD4CD25 T cells from
IL-2R/ recipient mice exhibited properties of regula- 5), hemolytic anemia (Figure 7C, group 5), and a periph-
eral T compartment that was hyporesponsive whentory T cells in vitro.
As mentioned above for IL-2R/ recipient mouse challenged in vitro (data not shown). In marked contrast,
none of these symptoms were seen in the adoptively#4, it seemed unlikely that donor CD8 T cells by them-
selves, that contaminated the transferred CD4CD25 transferred IL-2R/ mice (Figures 6D and 6E; Figures
7B–7D, group 7; data not shown). At this time, approxi-T cell preparations, were sufficient to suppress autoim-
munity in IL-2R/ mice. However, donor CD8 T cells mately 1% of the spleen and 2% of the lymph nodes
contained donor-derived CD45.1 T cells which corre-were also detected in the cured IL-2R/ recipients,
raising the possibility that these cells might act in con- sponded to 6.4 ( 1.3)  105 cells in these tissues or
on average at least a 6-fold expansion of the input donorcert with CD4CD25 T cells to prevent autoimmunity.
To investigate this possibility and to provide some initial inoculum. Importantly, FACS analysis indicated that ap-
proximately 95% of the CD45.1 donor cells were CD4information concerning the kinetics of engraftment by
donor CD4CD25 T cells, highly purified congenic T cells and essentially all these cells coexpressed CD25
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Figure 6. Adoptively Transferred CD4CD25 Regulatory T Cells Are Sufficient to Prevent Autoimmunity in IL-2R/ Mice
Ability of donor-derived CD4CD25 T cells to suppress anti-CD3-induced proliferation in vitro.
(A) FACS analysis of CD4CD25 T cells purified from C57BL/6 IL-2R/ or IL-2R/ recipient mice that received 1  105 congenic CD45.1
CD4CD25 T cells 8 weeks earlier. Numbers within the dot plots indicate the % of cells contained within the designated region.
(B) Anti-CD3-induced proliferation by unfractionated CD4 T cells was determined as described in the legend to Figure 2 by culturing the
indicated T cell populations (104 ) with anti-CD3 for 48 hr. Data are representative of three experiments. The purified CD4CD25 T cells
were derived from a control-treated IL-2R/ mouse or from treated IL-2R/ mouse #1, as represented in (A).
(C–F) Suppression of autoimmunity by highly purified CD4CD25 T cells. C57BL/6 IL-2R/ neonatal mice received 1  105 highly purified
CD45.1CD4CD25 T cells and were analyzed 26 days later. (C) Purity of adoptively transfer CD45.1 CD4CD25 T cells by FACS analysis.
(D) Cellularity of the axillary and brachial lymph nodes determined by manual hemacytometer counting obtained from mice of the indicated
IL-2R genotype listed below the x axis. (E) Summary of FACS analysis for recipient-derived splenic CD4 T cells that coexpressed CD69 for
mice of the indicated genotype listed below the x axis. (F) Summary of FACS analysis of the phenotype, as listed below the x axis, of CD45.1
donor-derived T cells from adoptively transferred IL-2R/ mice. FACS analysis was performed as described in the legend to Figure 5 for
expression of the indicated cell surface phenotype. Data in (D–F) were obtained from age-matched C57BL/6 IL-2R/ (n  5), IL-2R/ (n 
3), or adoptively transferred IL-2R/ mice (n  3; designated “treated/”).
(Figure 6F). As observed 7–9 weeks after adoptive trans- whereas Tg / CD4CD25 T cells expressed c but
not IL-2R (Figure 7A). Thus, wild-type CD4CD25 Tfer (see Figure 5E), all CD4CD25 T cells in these recipi-
ents were donor-derived and additionally displayed a cells express all subunits required for a functional high-
affinity IL-2R. To evaluate whether the expansion of nor-surface phenotype of CD25high, CD44high, CD45RBlow,
CD69neg/low, and CD62Lint (data not shown). Furthermore, mal CD4CD25 T cells in IL-2R/ mice required IL-2,
we investigated the capacity of adoptively transferredeven though expansion and engraftment of CD4CD25
T cells at 26 days was lower than mice analyzed 7–9 CD45.1 congenic C57BL/6 CD4CD25T cells to engraft
and prevent autoimmune disease in C57BL/6 IL-2/weeks after adoptive transfer, from 4%–9% of the CD4
T cells in the spleen or lymph nodes in these recipient mice. We similarly tested adoptively transferred Tg/
CD4CD25 T cells, which lacked detectable IL-2R,mice were CD4CD25 T cells, a proportion comparable
to that detected 7–9 weeks after transfer or in untreated to prevent autoimmunity in IL-2R/ mice. In marked
contrast to the obvious engraftment of normalnormal C57BL/6 mice. Thus, these data demonstrate a
close association between successful engraftment of CD4CD25 T cells in IL-2R/ mice (see Figure 5), 8
weeks after adoptive transfer of normal CD4CD25 Tfunctional CD4CD25 regulatory T cells in IL-2R/
mice with prevention of lethal autoimmunity and suggest cells into IL-2/ neonatal mice (n  4), essentially no
donor-derived cells (	0.1%) were detected in the spleenthat CD8 T cells do not obviously contribute to this
suppression. and lymph nodes from the recipient IL-2/ mice. Donor
T cells were similarly undetectable in one IL-2/ mouse
examined 4 weeks after adoptive transfer.IL-2 Is Essential for the Expansion of Adoptively
Transferred CD4CD25 T Cells In the absence of noticeable engraftment of donor
CD4CD25 T cells, the adoptively transferred IL-2/FACS analysis of normal C57BL/6 CD4CD25 T cells
revealed that these cells coexpressed IL-2R and c mice exhibited most symptoms of autoimmunity when
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Figure 7. Requirement for IL-2 in the Peripheral Expansion of CD4CD25 T Cells
(A) FACS analysis of expression of IL-2R subunits by splenic CD4CD25 T cells from normal C57BL/6 and Tg / mice. Expression of IL-
2R and c (shaded histograms) were evaluated after gating on CD4CD25 T cells, as indicated. The negative controls (open histograms)
were samples incubated with an excess of unlabeled anti-IL-2R or anti-c, as necessary, prior to adding the staining reagents.
(B–D) Ability of adoptively transferred CD4CD25 T cells to prevent autoimmunity in the absences of IL-2R signaling. Highly purified (see
Figure 6) syngeneic CD4CD25 T cells (1–2  105 ) from wild-type (WT) or Tg / C57BL/6 mice were adoptively transferred to neonatal
WT, IL-2/, or IL-2R/ mice, as indicated. (B) Cellularity of the axillary and brachial lymph nodes, (C) the hematocrit, or (D) the fraction of
CD4 lymph node T cells that coexpressed CD69 were determined 4 weeks later, except for groups 3 and 4, which were tested at 8 weeks
of age. The numbers to the right of the bars in (B) indicate the number of mice/group. The data in (C) and (D) include mice in (B) and relevant
data from the mice analyzed in Figure 6. The vertical line in (C) represents the lower limit for a normal hematocrit. Data are represented as
mean  SE.
assayed at 8 weeks of age. Similarly, IL-2R/ mice end of the normal range (Figure 7C, groups 3 versus 4
and 5 versus 8). Furthermore, the lymph nodes of IL-that received Tg/CD4CD25T cells exhibited signs
of autoimmunity at 4 weeks of age, consistent with the 2R/ mice that received Tg / CD4CD25 T cells
contained a significantly (t test, P value  0.0033) lowernotion that Tg / CD4CD25 T cells failed to engraft
the IL-2R/ recipient mice due to lack of a functional level of activated T cells when compared to untreated
IL-2R/ animals as assessed by the expression ofIL-2R, i.e., IL-2R, on the donor T cells. Although lymph-
oadenopathy is somewhat less severe in untreated IL- CD69 (Figure 7D, groups 5 versus 8) or CD62Lint/low (data
not shown). However, by 8 weeks of age, IL-2R/2/ versus IL-2R/ mice (Figure 7B, groups 3 versus
5), lymph node cellularity in the adoptively transferred mice that received Tg/CD4CD25 T cells exhibited
autoimmune disease comparable to IL-2R/ mice, in-IL-2/ mice was only slightly but not significantly (t
test) reduced when compared to untreated IL-2/ mice cluding hemolytic anemia (hematocrit, 0.35  0.04, n 
4) and a high fraction of activated peripheral T cells(Figure 7B, groups 3 versus 4). In addition, these lymph
nodes contained a high proportion of activated T cells, (% of CD4 T cells bearing CD69, 33.4  0.8, n  4).
Collectively, these data indicate that IL-2 or a functionalas represented by the fraction of CD4 T cells that coex-
pressed CD69, that paralleled the percentage seen for IL-2R is necessary for the initial expansion of adoptively
transferred CD4CD25 T cells and that this expansionuntreated IL-2/ mice (Figure 7D, groups 3 versus 4).
Similarly, at 4 weeks of age, lymphoadenopathy was is essential to prevent autoimmune disease. In the ab-
sence of IL-2-mediated expansion of CD4CD25 Tsimilar in untreated IL-2R/ mice and IL-2R/ mice
that received Tg / CD4CD25 T cells (Figure 7B, cells, it appears that the donor cell inoculum only delays
some symptoms associated with IL-2- or IL-2R defi-groups 5 versus 8).
Some autoimmune symptoms, nevertheless, were ciency.
prevented after the adoptive transfer of wild-type and
Tg / CD4CD25 T cells into IL-2/ or IL-2R/ Discussion
mice, respectively. When compared to untreated IL-2/
and IL-2R/ mice, both treatment groups lacked he- Gene knockout mouse models have clearly shown that
the nonredundant function of the IL-2/IL-2R system en-molytic anemia, as their hematocrits were at the low
Immunity
176
compasses its ability to maintain T cell homeostasis and autoimmune disease due to residual IL-2R signaling by
prevent self-reactivity (Sadlack et al., 1995, 1993; Suzuki peripheral CD4CD25 T cells. Nevertheless, even in
et al., 1995; Willerford et al., 1995). A major finding in the absence of detectable engraftment, several disease
this study is that this nonredundant IL-2/IL-2R activity symptoms associated with IL-2/IL-2R deficiency were
is related to its role in the production of CD4CD25 partially retarded, suggesting that these few cells medi-
regulatory T cells. There are three principal observations ated some suppressive activity. It is also important to
that support this conclusion. First, the production of emphasize that the failure of CD4CD25 T cells to en-
functional CD4CD25 T cells was reconstituted in graft normal control littermate mice provides additional
Tg / mice which are free from the autoimmune syn- evidence that donor CD4CD25 T cells fill an important
drome associated with IL-2R/ mice (Malek et al., cellular niche that is absent in IL-2R/ mice. Thus,
2000). Second, autoimmunity and imbalanced T cell ho- these observations indicate that the autoimmune pro-
meostasis were prevented by the adoptive transfer of tective component resides primarily, if not exclusively,
normal CD4CD25 T cells to IL-2R/ mice. This ob- within the CD4CD25 subset of T cells.
servation links the importance of the thymic-targeting Purified CD4CD25 T cells were approximately
of IL-2R as a transgene in IL-2R/ mice to the recon- 3-fold more efficient than unfractionated CD4 T cells
stitution of CD4CD25 T cells and suppression of auto- in preventing autoimmunity. As CD4CD25 represent
immunity. Lastly, IL-2 is required for the expansion of approximately 10% of CD4 T cells, we expected CD4
peripheral CD4CD25 T cells, as normal CD4CD25 CD25 T cells to be 10 more efficient than unfraction-
T cells did not engraft or prevent autoimmunity in IL- ated CD4 T cells if this was the sole subset of cells
2/ mice when administered to neonatal mice. that “cured” autoimmunity. This difference might simply
Although IL-2R/ mice generally lacked CD4 reflect that some CD4 regulatory T cells are CD4CD25,
CD25 T cells, more of these cells were detected in the as noted by others (Annacker et al., 2001; Stephens and
thymus than in the spleen and lymph nodes. Thus, one Mason, 2000), or an inefficiency in engraftment when
role for thymic IL-2R signaling might be to promote transferring a low number of CD4CD25 T cells. Alter-
the survival or growth of recently produced CD4CD25 natively, another subset of cells might also contribute
T cells. Another potential role for IL-2 in the thymus to suppressing autoimmunity. One candidate is CD8 T
might be to functionally program the inhibitory function cells, as normal CD8 T cells were shown to preferen-
of CD4CD25 T cells. These possibilities are not mutu- tially eliminate IL-2R/ T cells after adoptive transfer
ally exclusive and require further investigation. The ease to immunodeficient mice (Suzuki et al., 1999). However,
in detecting CD4CD25 T cells in spleen and lymph it is unlikely that these CD8 T cells substantially
nodes from Tg / mice raises the possibility that IL-2 suppressed autoimmunity because the one IL-2R/
may be dispensable for the survival of these cells, espe- recipient mouse (#4) engrafted with essentially only do-
cially as they lack expression of IL-2R. As CD4CD25 nor-derived CD8 T cells exhibited autoimmunity. Fur-
T cells are absent in both CD28/ and B7.1/B7.2/ thermore, three other autoimmune-free IL-2R/ mice,
mice, costimulatory signals may be sufficient to maintain that received highly purified CD4CD25 T cells, were
these regulatory T cells in the peripheral immune com- engrafted with essentially only CD4CD25high T cells
partment (Salomon et al., 2000). However, the high frac- while nearly lacking donor-derived CD8 T cells.
tion of CD4CD25 T cells in the spleen and lymph Two other recent studies have demonstrated the abil-
nodes of Tg/mice might also reflect constant thymic ity of normal T cells to control aspects of dysregulated
output of these cells which masked an essential role for T cell function associated with IL-2/IL-2R deficiency (Su-
IL-2/IL-2R in the periphery. zuki et al., 1999; Wolf et al., 2001). Our study represents a
When compared to CD4CD25 T cells, the adoptive substantial extension of these observations by showing
transfer of 10-fold fewer purified CD4CD25 prevented the actual autoimmune syndrome was prevented by the
lethal autoimmunity in BALB/c IL-2R/ mice. In six
transfer of normal CD4CD25 T cells to IL-2R/mice.
C57BL/6 IL-2R/ mice that lacked autoimmunity, the
Our findings and those by others (Suzuki et al., 1999;
major cellular population that engrafted these mice was
Wolf et al., 2001) provide a serious challenge to theCD4CD25 T cells. The engrafting CD4CD25 T cells
notion that a failure in AICD represents the primary rea-were further characterized as CD4 regulatory T cells by
son for the severe abnormalities associated with IL-2/their suppressive activity in vitro. In fact, essentially all
IL-2R deficiency in vivo. In each of these cases, thedonor T cells were CD4CD25 when IL-2R/ mice
administration of normal T cells averted dysregulatedwere examined 4 weeks after receiving highly purified
behavior by IL-2R/ T cells in vivo. In our study, afterCD4CD25 T cells. By using CD45.1 congenic T cells,
treatment of IL-2R/ neonates with normal CD4we calculated that donor CD4CD25 T cells expanded
CD25 T cells, 95% of the T cells in these recipientsat least 6- and 15- to 20-fold, 4 and 7–9 weeks after
were of host, i.e., IL-2R/, origin. If the nonredundanttransfer, respectively, but only in IL-2R/ recipient
activity of IL-2 was at the level of AICD, the IL-2R/mice. This expansion depended on IL-2 because normal
T cells in these treated mice were expected to showCD4CD25 T cells did not engraft or prevent disease
some signs of abnormal activation, lymphoproliferation,after transfer into IL-2/ neonatal mice. The inability
and self-reactivity, but this was not observed. It shouldof Tg / CD4CD25 T cells, that lacked detectable
also be emphasized that the peripheral T cell compart-expression of cell surface IL-2R, to prevent autoimmu-
ment of Tg/mice is also largely normal even thoughnity upon transfer to IL-2R/ mice is consistent with
these cells are essentially nonresponsive to IL-2 (Malekthe notion that IL-2R signaling is required for the expan-
et al., 2000, 2001). However, our study does not rulesion of these cells. Furthermore, this result further illus-
trates that it is highly unlikely that Tg / mice lacked out that IL-2 might redundantly function with other c-
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first 36 hr after birth by the i.v. injection of the indicated number ofdependent cytokines or other molecules to promote
purified T cells in 50 l of HBSS.AICD in vivo to limit immune responses.
Our work illustrates several new features concerning
Purification of CD4 T Cell Subsetsthe immunobiology of CD4 regulatory T cells. First, the
Unless otherwise indicated during the isolation procedures, cells
production of functional CD4CD25 T cells depends were always maintained or cultured in complete RPMI 1640 medium
upon the IL-2/IL-2R interaction that likely resides at two (CM) containing 5% FCS as described (Malek et al., 2000). To isolate
levels, i.e., during thymic development and for continued CD4 or CD4CD25 T cells, CD4 T cells were first enriched by
treating spleen cells with anti-CD8 (0.5 ml HO2.2 supernatant/100expansion of these cells in the periphery. The relative
106 cells for 15 min at 4C), and after washing 2 with HBSS, theimportance of thymic versus peripheral IL-2 for CD4
CD8 T cells and B cells were depleted on anti-Ig-coated plates byCD25 T cells in normal mice remains to be determined.
incubation for 45 min at room temperature, followed by collection
However, the lack of autoimmune disease in Tg / of the nonadherent cells. The anti-Ig coated plates were prepared
mice indicates that thymic IL-2R signaling is sufficient to by the addition of 5 ml/100 mm petri dish (Falcon 1001) with goat
prevent disease. Second, the autoimmune suppressive anti-mouse IgG and IgM (10 g/ml in PBS; Chemicon International,
Temecula, CA) for 1 hr at 37C or overnight at 4C, followed by threeactivity by CD4CD25 T cells has been extended to a
washes in HBSS to remove nonbound antibody. The viable enrichedsystemic form of autoimmunity. Most work to date has
CD4 T cells were obtained after centrifugation (1300 g for 20 min atimplicated CD4CD25 T cells in preventing organ-spe-
25C) through Lympholyte-M (Accurate Chemical & Scientific Corp.,
cific autoimmune disease (Sakaguchi, 2000; Shevach, Westbury, NY). To isolate purified CD4 T cells, the CD8- and Ig-
2000). Third, after adoptive transfer to IL-2R/ neo- depleted cells were incubated with anti-CD4 MACS MicroBeads in
nates, up to a 20-fold expansion of functional CD4 HBSS containing 5% FCS and 2 mM EDTA and positively selected
on MS MACS separation columns (Miltenyi Biotec, Auburn, CA)CD25 T cells occurred in a nonlymphopenic host. This
according to the manufacturer’s instructions. The purified CD4 Tdegree of expansion may still underestimate the prolifer-
cells were 
96% CD4 by FACS analysis (Figure 3A). To purifyative capacity of CD4CD25 T cells in vivo, as
CD4CD25 T cells, the CD8- and Ig-depleted cells (100  106 /
CD4CD25 T cells have been shown to undergo at ml) were incubated with biotin-conjugated anti-CD25 (10 g/ml) for
least six cell divisions in 	2 weeks when transferred to 15 min at 4C and washed 2 with HBSS containing 0.2% gelatin
lymphopenic RAG-2/ hosts (Annacker et al., 2001). and 2 mM EDTA, followed by incubation with streptavidin MACS
MicroBeads in the same buffer and positive selection on MS MACSMoreover, we showed that a single transfer of
separation columns. These cells were on average 92% CD4, ofCD4CD25 T cells led to stable engraftment and con-
which 96% were CD4CD25 by FACS analysis (Figure 3A). Highlytrol of autoimmunity for as long as 180 days. Therefore,
purified CD4CD25 T cells were obtained by positive selection of
these T cells substantially proliferated and survived in CD4CD25 T cells, as described above, by sequential passage
vivo. These findings are in marked contrast to in vitro through two MS MACS columns. Cell purity is shown in Figure 6C.
studies where CD4CD25 T cells are typically hypore- To prepare CD4CD25 T cells, splenic CD4 T cells were isolated
using anti-CD4 MACS MicroBeads as described above. These cellssponsive to stimulation through the TCR and are rela-
were stained with FITC-CD4, biotin-anti-CD25, and PE-streptavidin,tively difficult to propagate (Thornton and Shevach,
and the CD4CD25 T cells were isolated by cell sorting using a2000). Our finding that IL-2 appears to function as one
Becton Dickinson Vantage SE cell sorter. These cells were 
99%
essential growth factor for CD4CD25 T cells in vivo CD4 and contained approximately 2%–3% CD25 cells that
should facilitate strategies aimed at growing large num- stained with anti-CD25 at a low level. Alternatively, CD4CD25
bers of CD4CD25 regulatory T cells in vitro for thera- were also prepared by depleting CD25 cells in spleen cell suspen-
sions (50 106 /ml) by treatment with anti-CD25 (1:100 7D4 ascites),peutic purposes. Last, it should be emphasized that a
DNase I (10 g/ml; grade II; Boehringer Mannheim Corp., Indianapo-potential outcome of blocking the IL-2/IL-2R in vivo
lis, IN), and 10% low-tox rabbit complement (Accurate Chemical &might be induction of autoimmunity by affecting CD4
Scientific Corp., Westbury, NY) for 45 min at 37C. After washing
regulatory T cells. This might represent an unwanted 2 with HBSS, CD4 T cells were isolated using anti-CD4 MACS
consequence where the goal of a therapeutic protocol MicroBeads and MS separation columns. These cells were 87%
is to suppress immune responses. However, this may CD4 and contained approximately 1% CD25low cells (Figure 3A).
represent a novel approach to direct a T cell response
Antibodies and FACS Analysisto one’s own tissue which represents the primary objec-
Biotin-conjugated mAbs to IL-2R (TM1), CD69, V5, V6, V11,tive in tumor immunotherapy.
and V12, Cy-Chrome-conjugated mAbs to CD8, and CD4, phy-
coerythrin (PE)-conjugated anti-CD4, PE-anti-CD25 (PC61), PE-Experimental Procedures
streptavidin, PE-anti-c (4G3), and FITC-anti-TCR V subgroups
were purchased from Pharmingen (San Diego, CA). FITC-anti-CD4Mice and Neonatal Adoptive Transfer
(GK1.5), FITC-anti-CD45.1 (A20), unlabeled and biotin-anti-IL-2RC57BL/6, BALB/c, and DBA/2 mice were obtained from Jackson
(7D4), and biotin-conjugated mAbs to TCR (H57-597), V8.1.2.3Laboratories (Bar Harbor, ME). B6.SJL-Ptprc/BoAiTac mice, con-
(F23.1), V9 (MR10.2), V13 (MR12.4), CD44 (Pgp-1), and CD62Lgenic for CD45, were obtained from Taconic (Germantown, MD).
(Mel14) were prepared in our laboratory. FACS analysis was per-C57BL/6 IL-2/ mice were obtained from the Jackson Laboratories
formed as previously described (Malek et al., 1983) using a Becton-and bred in our animal colony to obtain IL-2/ mice. IL-2R/
Dickinson FACScan and CellQuest software.mice, backcrossed for at least five generations to C57BL/6 mice,
have been previously described (Suzuki et al., 1995) and were kindly
provided by Dr. Tak Mak (Ontario Cancer Institute, Toronto). IL- In Vitro Bioassays
T cell proliferation of spleen cells to PMA and cytokines or anti-2R/mice were intercrossed to generate C57BL/6 IL-2R/mice.
C57BL/6 IL-2R/ mice were backcrossed to BALB/c or DBA/2 CD3, the generation of anti-CD3-induced T cell blasts and their
subsequent proliferative responses to cytokines, and determinationmice for five generations, after which these IL-2R heterozygous
mice were intercrossed to generate BALB/c or DBA/2 IL-2R/ of hematocrits were performed exactly as previously described (Ma-
lek et al., 2000). Measurement of antinuclear antibodies (ANA) wasmice. The thymic targeted transgenic wild-type IL-2R expressed
in IL-2R/ mice on the C57BL/6 genetic background (designated performed using an ELISA kit (Alpha Diagnostic Int., San Antonio,
TX) according to the manufacturer’s instructions. The inhibitory ac-Tg / in this report) have been previously described (Malek et al.,
2000, 2001). Neonatal adoptive transfers were performed during the tivity of purified CD4CD25 T cells (5  104 ) was assessed by
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culturing these T cells with unfractionated purified CD4 T cells growth to multiple cytokines and functional maturation of antigen-
activated T cells. J. Immunol. 166, 1675–1683.(5–10  104 ) and mitomycin-treated anti-Thy-1 and complement-
treated spleen cells (5  104 ) (Malek et al., 2001) in 96-well round Nelson, B.H., and Willerford, D.M. (1998). Biology of the interleukin-2
bottom microtiter wells with anti-CD3 (1 g/ml) for 48 hr. 3 H-thymi- receptor. Adv. Immunol. 70, 1–81.
dine was added during the last 4–6 hr of culture. Papiernik, M., de Moraes, M.L., Pontoux, C., Vasseur, F., and Penit,
C. (1997). Regulatory CD4 T cells: expression of IL-2R chain, resis-
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